Respiratory Inhaler Devices MarketThe global respiratory inhaler devices market, valued at USD 37,258.5 million in 2023, is projected to grow at a compound annual growth rate (CAGR) of 4.90%, reaching ...

Winter is prime time for COPD. You can’t get rid of the disease, but treatment can improve quality of life.Key takeaways:COPD ...

Understand the role of palliative care and hospice for COPD patients. COPD Pharmacological Management Identify medications used in COPD management and differentiate between action pathways of common ...

Supported by regular phone calls or other contact to ensure that necessary medications and the like are adhered to, individualized management plans can result in better quality of life and fewer ...

Alexander Mathioudakis, MD, PhD, clinical lecturer in respiratory medicine at The University of Manchester, discusses insights from the FLAME trial analysis and the ICS-RECODE meta-analysis.

An estimated 30 million Americans are affected by chronic obstructive pulmonary disease (COPD), but surprisingly, only 17 million have received a diagnosis. Texas alone accounts for 1.2 million of ...

3/4 inhibitor – now given the somewhat tongue-twisting brand name of Ohtuvayre – is the first inhaled product with a novel mechanism of action available for the maintenance treatment of COPD ...

At the moment, the recommended treatment for COPD in Europe is an inhaled corticosteroid (ICS), a long-acting beta-agonist (LABA) and long-acting muscarinic antagonist (LAMA), or LABA/LAMA dual ...

There is no cure for COPD, but it can be managed and treated by working with your healthcare team to develop a plan to keep your COPD under control. Along with quitting smoking, staying up to date ...

He added, "And many of our patients have come with severe exacerbation, what we call a severe worsening of symptoms. And many ...